These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22716658)

  • 1. IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse.
    Kostek MC; Nagaraju K; Pistilli E; Sali A; Lai SH; Gordon B; Chen YW
    BMC Musculoskelet Disord; 2012 Jun; 13():106. PubMed ID: 22716658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of respiratory function in mdx mice co-treated with neutralizing interleukin-6 receptor antibodies and urocortin-2.
    Burns DP; Canavan L; Rowland J; O'Flaherty R; Brannock M; Drummond SE; O'Malley D; Edge D; O'Halloran KD
    J Physiol; 2018 Nov; 596(21):5175-5197. PubMed ID: 30160301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
    Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
    Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Dystrophic
    Addinsall AB; Forgan LG; McRae NL; Kelly RW; McDonald PL; McNeill B; McCulloch DR; Stupka N
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32156081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.
    Villalta SA; Rinaldi C; Deng B; Liu G; Fedor B; Tidball JG
    Hum Mol Genet; 2011 Feb; 20(4):790-805. PubMed ID: 21118895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 6 induces overexpression of the sarcolemmal utrophin in neonatal mdx skeletal muscle.
    Fujimori K; Itoh Y; Yamamoto K; Miyagoe-Suzuki Y; Yuasa K; Yoshizaki K; Yamamoto H; Takeda S
    Hum Gene Ther; 2002 Mar; 13(4):509-18. PubMed ID: 11874629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice.
    Morris CA; Selsby JT; Morris LD; Pendrak K; Sweeney HL
    J Appl Physiol (1985); 2010 Nov; 109(5):1492-9. PubMed ID: 20847128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.
    Manning J; Kulbida R; Rai P; Jensen L; Bouma J; Singh SP; O'Malley D; Yilmazer-Hanke D
    Exp Physiol; 2014 Oct; 99(10):1370-86. PubMed ID: 24972834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid Receptor Antagonists in Muscular Dystrophy Mice During Aging and Exercise.
    Lowe J; Kadakia FK; Zins JG; Haupt M; Peczkowski KK; Rastogi N; Floyd KT; Gomez-Sanchez EP; Gomez-Sanchez CE; Elnakish MT; Rafael-Fortney JA; Janssen PML
    J Neuromuscul Dis; 2018; 5(3):295-306. PubMed ID: 30010143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis.
    Gazzerro E; Baldassari S; Assereto S; Fruscione F; Pistorio A; Panicucci C; Volpi S; Perruzza L; Fiorillo C; Minetti C; Traggiai E; Grassi F; Bruno C
    Am J Pathol; 2015 Dec; 185(12):3349-60. PubMed ID: 26465071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.
    Benny Klimek ME; Sali A; Rayavarapu S; Van der Meulen JH; Nagaraju K
    PLoS One; 2016; 11(5):e0155944. PubMed ID: 27213537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
    Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
    Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.
    Krishnan SM; Nordlohne J; Dietz L; Vakalopoulos A; Haning P; Hartmann E; Seifert R; Hüser J; Mathar I; Sandner P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
    Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
    Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.